Vertex Pharmaceuticals Inc (VRTX)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	9,803,200	8,863,500	7,499,400	6,135,450	4,105,510
Property, plant and equipment	US$ in thousands	886,500	792,900	694,000	527,300	745,080
Fixed asset turnover		11.06	11.18	10.81	11.64	5.51

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $9,803,200K ÷ $886,500K
= 11.06

Vertex Pharmaceuticals, Inc.'s fixed asset turnover has been showing a positive trend over the past five years, indicating the company's ability to generate revenue efficiently from its fixed assets. The ratio has consistently increased from 5.59 in 2019 to 8.51 in 2023. This improvement suggests that Vertex Pharmaceuticals has been effectively utilizing its fixed assets to generate sales revenue, reflecting operational efficiency and potentially effective management of investments in property, plant, and equipment. Overall, the increasing trend in fixed asset turnover signifies a positive aspect of Vertex Pharmaceuticals' financial performance and operational effectiveness over the years.